• 5064 Citations
  • 20 Scopus h-Index
20082019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2008 2019

  • 5064 Citations
  • 20 Scopus h-Index
  • 54 Article
  • 5 Review article
  • 2 Chapter
  • 1 Comment/debate
Filter
Article
2019
2 Citations (Scopus)

Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine

Vera, J., Paludo, J., Kottschade, L., Brandt, J., Yan, Y., Block, M. S., Mc Williams, R. R., Dronca, R. S., Loprinzi, C. L., Grothey, A. F. & Markovic, S. N., Jan 1 2019, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Colchicine
Fever
Mitogen-Activated Protein Kinases
Familial Mediterranean Fever
Therapeutics
35 Citations (Scopus)

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., Dronca, R. S., Mitchell, T. C., Patnaik, A., Zarour, H. M., Joshua, A. M., Zhao, Q., Jensen, E., Ahsan, S., Ibrahim, N. & Ribas, A., Apr 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 582-588 7 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
Survival
Disease-Free Survival
pembrolizumab
Therapeutics
1 Citation (Scopus)

Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT

Evans, J. D., Morris, L. K., Zhang, H., Cao, S., Liu, X., Mara, K. C., Stish, B. J., Davis, B. J., Mansfield, A., Dronca, R. S., Iott, M. J., Kwon, E. D., Foote, R. L., Olivier, K. R., Dong, H. M. & Park, S. S., Jan 1 2019, In : International Journal of Radiation Oncology Biology Physics. 103, 1, p. 229-240 12 p.

Research output: Contribution to journalArticle

Immunophenotyping
metastasis
Prostatic Neoplasms
cancer
Neoplasm Metastasis
3 Citations (Scopus)

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Programmed Cell Death 1 Receptor
Non-Small Cell Lung Carcinoma
Sex Characteristics
Melanoma
Therapeutics
2018
45 Citations (Scopus)

Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab

Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W. J., Wolchok, J. D., Joshua, A. M., Ribas, A., Hodi, F. S., Hamid, O., Robert, C., Daud, A., Dronca, R. S., Hersey, P., Weber, J. S., Patnaik, A., De Alwis, D. P., Perrone, A., Zhang, J., Kang, S. P., Ebbinghaus, S. & 2 others, Anderson, K. M. & Gangadhar, T. C., Oct 15 2018, In : Clinical Cancer Research. 24, 20, p. 4960-4967 8 p.

Research output: Contribution to journalArticle

Melanoma
Survival
Neoplasms
pembrolizumab
Ligands
19 Citations (Scopus)

Contraction of T cell richness in lung cancer brain metastases

Mansfield, A., Ren, H., Sutor, S., Sarangi, V., Nair, A., Davila, J., Elsbernd, L. R., Udell, J. B., Dronca, R. S., Park, S. S., Markovic, S. N., Sun, Z. D., Halling, K. C., Nevala, W. K., Aubry, M. C., Dong, H. M. & Jen, J., Dec 1 2018, In : Scientific Reports. 8, 1, 2171.

Research output: Contribution to journalArticle

Brain Neoplasms
Lung Neoplasms
Clone Cells
Neoplasm Metastasis
T-Lymphocytes
13 Citations (Scopus)

CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Yan, Y., Cao, S., Liu, X., Harrington, S. M., Bindeman, W. E., Adjei, A. A., Jang, J. S., Jen, J., Li, Y., Chanana, P., Mansfield, A. S., Park, S. S., Markovic, S. N., Dronca, R. S. & Dong, H., Apr 19 2018, In : JCI insight. 3, 8

Research output: Contribution to journalArticle

Open Access
T-Lymphocytes
Drug Therapy
Aptitude
Neoplasms
Therapeutics
95 Citations (Scopus)

Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma

Robert, C., Ribas, A., Hamid, O., Daud, A., Wolchok, J. D., Joshua, A. M., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Joseph, R. W., Dronca, R. S., Patnaik, A., Zarour, H., Kefford, R., Hersey, P., Zhang, J., Anderson, J., Diede, S. J., Ebbinghaus, S. & Hodi, F. S., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1668-1674 7 p.

Research output: Contribution to journalArticle

Melanoma
pembrolizumab
Observation
Therapeutics
Disease-Free Survival
2017
7 Citations (Scopus)

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma

Youland, R. S., Packard, A. T., Blanchard, M. J., Arnett, A. L., Wiseman, G. A., Kottschade, L. A., Dronca, R. S., Markovic, S. N., Olivier, K. R. & Park, S. S., Apr 1 2017, In : Advances in Radiation Oncology. 2, 2, p. 204-210 7 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Positron-Emission Tomography
Melanoma
Radiotherapy
Neoplasm Metastasis
6 Citations (Scopus)

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Leon-Ferre, R. A., Kottschade, L. A., Block, M. S., Mc Williams, R. R., Dronca, R. S., Creagan, E. T., Allred, J. B., Lowe, V. & Markovic, S. N., Mar 14 2017, (Accepted/In press) In : Melanoma Research.

Research output: Contribution to journalArticle

Melanoma
Recurrence
Salvage Therapy
Confidence Intervals
Survival
6 Citations (Scopus)

Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patients

Leontovich, A. A., Dronca, R. S., Nevala, W. K., Thompson, M. A., Kottschade, L. A., Ivanov, L. V. & Markovic, S. N., 2017, In : Melanoma Research. 27, 1, p. 32-42 11 p.

Research output: Contribution to journalArticle

Monocytes
Melanoma
Lymphocytes
Drug Therapy
Neoplasms
6 Citations (Scopus)

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program

Gangadhar, T. C., Hwu, W. J., Postow, M. A., Hamid, O., Daud, A., Dronca, R. S., Joseph, R. W., O'Day, S. J., Hodi, F. S., Pavlick, A. C., Kluger, H., Oxborough, R. P., Yang, A., Gazdoiu, M., Kush, D. A., Ebbinghaus, S. & Salama, A. K. S., 2017, In : Journal of Immunotherapy. 40, 9, p. 334-340 7 p.

Research output: Contribution to journalArticle

Safety
Melanoma
Confidence Intervals
Therapeutics
pembrolizumab
15 Citations (Scopus)

Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy

Enninga, E. A. L., Harrington, S. M., Creedon, D. J., Ruano, R., Markovic, S. N., Dong, H. M. & Dronca, R. S., Jan 1 2017, (Accepted/In press) In : American Journal of Reproductive Immunology.

Research output: Contribution to journalArticle

Galectin 1
Galectins
Ligands
Pregnancy
Fetus
1 Citation (Scopus)

Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors — a major reason for enhanced chemosensitivity?

Shenoy, N., Dronca, R. S., Quevedo, F., Boorjian, S. A., Cheville, J., Costello, B., Kohli, M., Witzig, T. E. & Pagliaro, L., Aug 1 2017, In : Chinese Journal of Cancer Research. 29, 4, p. 374-378 5 p.

Research output: Contribution to journalArticle

Hypoxia-Inducible Factor 1
Germ Cell and Embryonal Neoplasms
Platinum
Cisplatin
DNA Damage
4 Citations (Scopus)

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab±everolimus for metastatic melanoma

Mc Williams, R. R., Allred, J. B., Slostad, J. A., Katipamula, R., Dronca, R. S., Rumilla, K. M., Erickson, L. A., Bryce, A. H., Joseph, R. W., Kottschade, L. A., King, D. M., Leitch, J. M. & Markovic, S. N., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Disease-Free Survival
Therapeutics
1 Citation (Scopus)

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era

Youland, R. S., Blanchard, M. L., Dronca, R. S., Kottschade, L., Markovic, S. N., Olivier, K. R. & Park, S. S., Oct 1 2017, In : Clinical and Translational Radiation Oncology. 6, p. 25-30 6 p.

Research output: Contribution to journalArticle

Open Access
Radiosurgery
Melanoma
Radiotherapy
Neoplasm Metastasis
Survival
15 Citations (Scopus)

Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011

Enninga, E. A. L., Moser, J. C., Weaver, A. L., Markovic, S. N., Brewer, J. D., Leontovich, A. A., Hieken, T. J., Shuster, L., Kottschade, L. A., Olariu, A., Mansfield, A. & Dronca, R. S., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Melanoma
Skin
Age Groups
Survival
Gonadal Steroid Hormones
6 Citations (Scopus)

Whole blood mRNA expression-based prognosis of metastatic renal cell carcinoma

Giridhar, K., Sosa, C. P., Hillman, D. W., Sanhueza, C., Dalpiaz, C. L., Costello, B., Quevedo, F. J., Pitot, H. C., Dronca, R. S., Ertz, D., Cheville, J., Donkena, K. V. & Kohli, M., Nov 3 2017, In : International Journal of Molecular Sciences. 18, 11, 2326.

Research output: Contribution to journalArticle

prognosis
Renal Cell Carcinoma
blood
Blood
Genes
2016
425 Citations (Scopus)

Association of pembrolizumab with tumor response and survival among patients with advanced melanoma

Ribas, A., Hamid, O., Daud, A., Hodi, F. S., Wolchok, J. D., Kefford, R., Joshua, A. M., Patnaik, A., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Hersey, P., Dronca, R. S., Joseph, R. W., Zarour, H., Chmielowski, B., Lawrence, D. P., Algazi, A., Rizvi, N. A., Hoffner, B. & 8 others, Mateus, C., Gergich, K., Lindia, J. A., Giannotti, M., Li, X. N., Ebbinghaus, S., Kang, S. P. & Robert, C., Apr 19 2016, In : JAMA - Journal of the American Medical Association. 315, 15, p. 1600-1609 10 p.

Research output: Contribution to journalArticle

Melanoma
Survival
Neoplasms
Survival Rate
Disease-Free Survival

A T cell memory problem?

Dronca, R. S., Jan 20 2016, In : Science Translational Medicine. 8, 322, 322ec10.

Research output: Contribution to journalArticle

T-Lymphocytes
321 Citations (Scopus)

Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab

Hodi, F. S., Hwu, W. J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., Joshua, A. M., Hersey, P., Dronca, R. S., Joseph, R. W., Hille, D., Xue, D., Li, X. N., Kang, S. P., Ebbinghaus, S., Perrone, A. & 1 others, Wolchok, J. D., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

Melanoma
Immune System Diseases
Response Evaluation Criteria in Solid Tumors
pembrolizumab
Withholding Treatment
204 Citations (Scopus)

Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma

Daud, A. I., Wolchok, J. D., Robert, C., Hwu, W. J., Weber, J. S., Ribas, A., Hodi, F. S., Joshua, A. M., Kefford, R., Hersey, P., Joseph, R. W., Gangadhar, T. C., Dronca, R. S., Patnaik, A., Zarour, H., Roach, C., Toland, G., Lunceford, J. K., Li, X. N., Emancipator, K. & 4 others, Dolled-Filhart, M., Kang, S. P., Ebbinghaus, S. & Hamid, O., Dec 1 2016, In : Journal of Clinical Oncology. 34, 34, p. 4102-4109 8 p.

Research output: Contribution to journalArticle

Melanoma
Ligands
Antibodies
Disease-Free Survival
Neoplasms
115 Citations (Scopus)
Lung Neoplasms
Cell Death
Tumor-Infiltrating Lymphocytes
Tumor Microenvironment
Lymphocytes
43 Citations (Scopus)

The use of pembrolizumab for the treatment of metastatic uveal melanoma

Kottschade, L. A., Mc Williams, R. R., Markovic, S. N., Block, M. S., Villasboas Bisneto, J. J. C. ., Pham, A. Q., Esplin, B. L. & Dronca, R. S., Feb 4 2016, (Accepted/In press) In : Melanoma Research.

Research output: Contribution to journalArticle

Therapeutics
Uveal melanoma
pembrolizumab
Central Nervous System Diseases
Disease-Free Survival

Turning BiKEs into TriKEs to fight cancer

Dronca, R. S., Mar 2 2016, In : Science Translational Medicine. 8, 328, 328ec35.

Research output: Contribution to journalArticle

Neoplasms
2015
6 Citations (Scopus)

A gender factor in shaping T-cell immunity to melanoma

Dronca, R. S. & Dong, H. M., 2015, In : Frontiers in Oncology. 5, FEB, 8.

Research output: Contribution to journalArticle

Immunity
Melanoma
T-Lymphocytes
7 Citations (Scopus)

Immunomodulatory antibody therapy of Cancer: The closer, the better

Dronca, R. S. & Dong, H. M., Mar 1 2015, In : Clinical Cancer Research. 21, 5, p. 944-946 3 p.

Research output: Contribution to journalArticle

Immunomodulation
Antibodies
Neoplasms
Therapeutic Uses
Therapeutics

Immunotherapy: Fast and furious: Why all CARs are not made equal

Dronca, R. S., May 27 2015, In : Science Translational Medicine. 7, 289, 289ec86.

Research output: Contribution to journalArticle

Immunotherapy

It takes three to tango

Dronca, R. S., Sep 9 2015, In : Science Translational Medicine. 7, 304, 304ec153.

Research output: Contribution to journalArticle

Not just a fecal matter

Dronca, R. S., Dec 2 2015, In : Science Translational Medicine. 7, 316, 8023.

Research output: Contribution to journalArticle

25 Citations (Scopus)
Phosphotransferases
Survival
Therapeutics
Eye Neoplasms
Proxy

To beam or not to beam

Dronca, R. S., Oct 21 2015, In : Science Translational Medicine. 7, 310, 310ec179.

Research output: Contribution to journalArticle

When instability is a good thing

Dronca, R. S., Jun 17 2015, In : Science Translational Medicine. 7, 292, 292ec100.

Research output: Contribution to journalArticle

Why location is (still) everything

Dronca, R. S., Jul 29 2015, In : Science Translational Medicine. 7, 298, 298ec128.

Research output: Contribution to journalArticle

2014
1074 Citations (Scopus)

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial

Robert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W. J., Gangadhar, T. C., Patnaik, A., Dronca, R. S., Zarour, H., Joseph, R. W., Boasberg, P., Chmielowski, B., Mateus, C., Postow, M. A., Gergich, K., Elassaiss-Schaap, J. & 5 others, Li, X. N., Iannone, R., Ebbinghaus, S. W., Kang, S. P. & Daud, A., Sep 20 2014, In : The Lancet. 384, 9948, p. 1109-1117 9 p.

Research output: Contribution to journalArticle

Death Domain Receptors
Melanoma
Therapeutics
Fatigue
Appointments and Schedules
3 Citations (Scopus)
Local Neoplasm Recurrences
Adrenergic beta-Antagonists
Antihypertensive Agents
Melanoma
Hypertension
33 Citations (Scopus)

Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients

Thompson, R. H., Boorjian, S. A., Kim, S. P., Cheville, J. C., Thapa, P., Tarrel, R., Dronca, R. S., Costello, B. & Frank, I., 2014, In : BJU International. 113, 5 B

Research output: Contribution to journalArticle

Cystectomy
Cisplatin
Glomerular Filtration Rate
Drug Therapy
Hydronephrosis
21 Citations (Scopus)

Immunomodulatory effects of sex hormones: Requirements for pregnancy and relevance in melanoma

Enninga, E. A. L., Holtan, S. G., Creedon, D. J., Dronca, R. S., Nevala, W. K., Ognjanovic, S. & Markovic, S. N., 2014, In : Mayo Clinic Proceedings. 89, 4, p. 520-535 16 p.

Research output: Contribution to journalArticle

Gonadal Steroid Hormones
Melanoma
Pregnancy
Neoplasms
Immunity
28 Citations (Scopus)

Increasing incidence of melanoma among middle-aged adults: An epidemiologic study in olmsted county, minnesota

Lowe, G. C., Saavedra, A., Reed, K. B., Velazquez, A. I., Dronca, R. S., Markovic, S. N., Lohse, C. M. & Brewer, J. D., 2014, In : Mayo Clinic Proceedings. 89, 1, p. 52-59 8 p.

Research output: Contribution to journalArticle

Epidemiologic Studies
Melanoma
Incidence
Cause of Death
Skin
55 Citations (Scopus)

Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma

Shah, D. J. & Dronca, R. S., 2014, In : Mayo Clinic Proceedings. 89, 4, p. 504-519 16 p.

Research output: Contribution to journalArticle

Melanoma
CD274 Antigen
Therapeutics
Mitogen-Activated Protein Kinases
Programmed Cell Death 1 Receptor
20 Citations (Scopus)

Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: A north central cancer treatment group study, N0675

Dronca, R. S., Allred, J. B., Perez, D. G., Nevala, W. K., Lieser, E. A. T., Thompson, M., Maples, W. J., Creagan, E. T., Pockaj, B. A., Kaur, J. S., Moore, T. D., Marchello, B. T. & Markovic, S. N., 2014, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 37, 4, p. 369-376 8 p.

Research output: Contribution to journalArticle

temozolomide
Melanoma
Neoplasms
Sirolimus
Therapeutics
8 Citations (Scopus)

Rare presentations of primary melanoma and special populations: A systematic review

Kottschade, L. A., Grotz, T. E., Dronca, R. S., Salomao, D. R., Pulido, J. S., Wasif, N., Jakub, J. W., Bagaria, S. P., Kumar, R., Kaur, J. S., Morita, S. Y., Moran, S. L., Nguyen, J. T., Nguyen, E. C., Hand, J. L., Erickson, L. A., Brewer, J. D., Baum, C., Miller, R. C., Swanson, D. L. & 2 others, Lowe, V. & Markovic, S. N., Dec 11 2014, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 37, 6, p. 635-641 7 p.

Research output: Contribution to journalArticle

Melanoma
Population
Gastrointestinal Tract
Neck
Head
2013
28 Citations (Scopus)

Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up

Zhang, B. Y., Thompson, R. H., Lohse, C. M., Dronca, R. S., Cheville, J. C., Kwon, E. D. & Leibovich, B. C., Jun 2013, In : BJU International. 111, 7, p. 1046-1053 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Neoplasm Metastasis
Proportional Hazards Models
Carbonic Anhydrase IX
Neoplasms
11 Citations (Scopus)

Cardiac metastasis in renal cell carcinoma without vena cava or atrial involvement: An unusual presentation of metastatic disease

Zhang, B., Malouf, J., Young, P., Kohli, M. & Dronca, R. S., 2013, In : Rare Tumors. 5, 3, p. 103-105 3 p.

Research output: Contribution to journalArticle

Venae Cavae
Renal Cell Carcinoma
Neoplasm Metastasis
Heart Ventricles
Case Management
19 Citations (Scopus)

NUT midline carcinoma: An aggressive intrathoracic neoplasm

Parikh, S. A., French, C. A., Costello, B., Marks, R. S., Dronca, R. S., Nerby, C. L., Roden, A., Peddareddigari, V. G., Hilton, J., Shapiro, G. I. & Molina, J. R., 2013, In : Journal of Thoracic Oncology. 8, 10, p. 1335-1338 4 p.

Research output: Contribution to journalArticle

Nuclear Proteins
Testis
Carcinoma
Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 15
2154 Citations (Scopus)

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., Dronca, R. S., Gangadhar, T. C., Patnaik, A., Zarour, H., Joshua, A. M., Gergich, K., Elassaiss-Schaap, J., Algazi, A., Mateus, C., Boasberg, P. & 6 others, Tumeh, P. C., Chmielowski, B., Ebbinghaus, S. W., Li, X. N., Kang, S. P. & Ribas, A., 2013, In : New England Journal of Medicine. 369, 2, p. 134-144 11 p.

Research output: Contribution to journalArticle

Melanoma
Safety
Neoplasms
Confidence Intervals
Therapeutics
2012
11 Citations (Scopus)

Fluctuation of systemic immunity in melanoma and implications for timing of therapy

Leontovich, A. A., Dronca, R. S., Suman, V. J., Ashdown, M. L., Nevala, W. K., Thompson, M. A., Robinson, A., Kottschade, L. A., Kaur, J. S., Mc Williams, R. R., Ivanov, L. V., Croghan, G. A. & Markovic, S. N., Jan 1 2012, In : Frontiers in Bioscience - Elite. 4 E, 3, p. 958-975 18 p.

Research output: Contribution to journalArticle

Biomarkers
Immunity
Melanoma
Chemotherapy
temozolomide
35 Citations (Scopus)

Melanoma brain metastases and vemurafenib: Need for further investigation

Rochet, N. M., Dronca, R. S., Kottschade, L. A., Chavan, R. N., Gorman, B., Gilbertson, J. R. & Markovic, S. N., 2012, In : Mayo Clinic Proceedings. 87, 10, p. 976-981 6 p.

Research output: Contribution to journalArticle

Melanoma
Neoplasm Metastasis
Brain
Brain Diseases
United States Food and Drug Administration
39 Citations (Scopus)
Th2 Cells
Chemokine CCL2
T-Lymphocytes
MART-1 Antigen
Blood Donors
5 Citations (Scopus)

Personalized therapy for metastatic melanoma: Could timing be everything?

Dronca, R. S., Leontovich, A. A., Nevala, W. K. & Markovic, S. N., Nov 2012, In : Future Oncology. 8, 11, p. 1401-1406 6 p.

Research output: Contribution to journalArticle

temozolomide
Periodicity
Melanoma
Humoral Immunity
Cellular Immunity